Eurordis pleads for an equitable access to therapies of patients suffering from a rare disease
In April 2021, Eurordis seized the occasion of the current revision of the revision of the EU pharmaceutical legislation to plead for an equitable access to therapies of patients suffering from a rare disease. Read their full press release by clicking on the following link.
On the same topic, read their full reflection paper from February 2017 entitled “Breaking the Access Deadlock to Leave No One Behind. A work-in-progress contribution on possibilities for patients’ full and equitable access to rare disease therapies“.
OpenEdition vous propose de citer ce billet de la manière suivante :
egennet (19 août 2021). Eurordis pleads for an equitable access to therapies of patients suffering from a rare disease. ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/o5s3